Cargando…
Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS)
COPD has a profound impact on daily life, yet remains underdiagnosed and undertreated. We set out to develop a brief, reliable, self-scored questionnaire to identify individuals likely to have COPD. COPD-PS™ development began with a list of concepts identified for inclusion using expert opinion from...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430173/ https://www.ncbi.nlm.nih.gov/pubmed/18415807 http://dx.doi.org/10.1080/15412550801940721 |
_version_ | 1782156361093611520 |
---|---|
author | Martinez, Fernando J. Raczek, Anastasia E. Seifer, Frederic D. Conoscenti, Craig S. Curtice, Tammy G. D'Eletto, Thomas Cote, Claudia Hawkins, Clare Phillips, Amy L. |
author_facet | Martinez, Fernando J. Raczek, Anastasia E. Seifer, Frederic D. Conoscenti, Craig S. Curtice, Tammy G. D'Eletto, Thomas Cote, Claudia Hawkins, Clare Phillips, Amy L. |
author_sort | Martinez, Fernando J. |
collection | PubMed |
description | COPD has a profound impact on daily life, yet remains underdiagnosed and undertreated. We set out to develop a brief, reliable, self-scored questionnaire to identify individuals likely to have COPD. COPD-PS™ development began with a list of concepts identified for inclusion using expert opinion from a clinician working group comprised of pulmonologists (n = 5) and primary care clinicians (n = 5). A national survey of 697 patients was conducted at 12 practitioner sites. Logistic regression identified items discriminating between patients with and without fixed airflow obstruction (AO, postbronchodilator FEV(1)/FVC < 70%). ROC analyses evaluated screening accuracy, compared scoring options, and assessed concurrent validity. Convergent and discriminant validity were assessed via COPD-PS and SF-12v2 score correlations. For known-groups validation, COPD-PS differences between clinical groups were tested. Test-retest reliability was evaluated in a 20% sample. Of 697 patients surveyed, 295 patients met expert review criteria for spirometry performance; 38% of these (n = 113) had results indicating AO. Five items positively predicted AO (p < 0.0001): breathlessness, productive cough, activity limitation, smoking history, and age. COPD-PS scores accurately classified AO status (area under ROC curve = 0.81) and reliable (r = 0.91). Patients with spirometry indicative of AO scored significantly higher (6.8, SD = 1.9; p < 0.0001) than patients without AO (4.0, SD = 2.3). Higher scores were associated with more severe AO, bronchodilator use, and overnight hospitalization for breathing problems. With the prevalence of COPD in the studied cohort, a score on the COPD-PS of greater than five was associated with a positive predictive value of 56.8% and negative predictive value of 86.4%. The COPD-PS accurately classified physician-reported COPD (AUC = 0.89). The COPD-PS is a brief, accurate questionnaire that can identify individuals likely to have COPD. |
format | Text |
id | pubmed-2430173 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Informa Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-24301732008-06-27 Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS) Martinez, Fernando J. Raczek, Anastasia E. Seifer, Frederic D. Conoscenti, Craig S. Curtice, Tammy G. D'Eletto, Thomas Cote, Claudia Hawkins, Clare Phillips, Amy L. COPD Original Research COPD has a profound impact on daily life, yet remains underdiagnosed and undertreated. We set out to develop a brief, reliable, self-scored questionnaire to identify individuals likely to have COPD. COPD-PS™ development began with a list of concepts identified for inclusion using expert opinion from a clinician working group comprised of pulmonologists (n = 5) and primary care clinicians (n = 5). A national survey of 697 patients was conducted at 12 practitioner sites. Logistic regression identified items discriminating between patients with and without fixed airflow obstruction (AO, postbronchodilator FEV(1)/FVC < 70%). ROC analyses evaluated screening accuracy, compared scoring options, and assessed concurrent validity. Convergent and discriminant validity were assessed via COPD-PS and SF-12v2 score correlations. For known-groups validation, COPD-PS differences between clinical groups were tested. Test-retest reliability was evaluated in a 20% sample. Of 697 patients surveyed, 295 patients met expert review criteria for spirometry performance; 38% of these (n = 113) had results indicating AO. Five items positively predicted AO (p < 0.0001): breathlessness, productive cough, activity limitation, smoking history, and age. COPD-PS scores accurately classified AO status (area under ROC curve = 0.81) and reliable (r = 0.91). Patients with spirometry indicative of AO scored significantly higher (6.8, SD = 1.9; p < 0.0001) than patients without AO (4.0, SD = 2.3). Higher scores were associated with more severe AO, bronchodilator use, and overnight hospitalization for breathing problems. With the prevalence of COPD in the studied cohort, a score on the COPD-PS of greater than five was associated with a positive predictive value of 56.8% and negative predictive value of 86.4%. The COPD-PS accurately classified physician-reported COPD (AUC = 0.89). The COPD-PS is a brief, accurate questionnaire that can identify individuals likely to have COPD. Informa Healthcare 2008-04-15 2008-04 /pmc/articles/PMC2430173/ /pubmed/18415807 http://dx.doi.org/10.1080/15412550801940721 Text en © Informa Healthcare USA, Inc. http://creativecommons.org/licenses/by/2.0/ This is an open access article distributed under the Supplemental Terms and Conditions for iOpenAccess articles published in Informa Healthcare journals (http://www.informaworld.com/mpp/uploads/iopenaccess_tcs.pdf) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Martinez, Fernando J. Raczek, Anastasia E. Seifer, Frederic D. Conoscenti, Craig S. Curtice, Tammy G. D'Eletto, Thomas Cote, Claudia Hawkins, Clare Phillips, Amy L. Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS) |
title | Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS) |
title_full | Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS) |
title_fullStr | Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS) |
title_full_unstemmed | Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS) |
title_short | Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS) |
title_sort | development and initial validation of a self-scored copd population screener questionnaire (copd-ps) |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430173/ https://www.ncbi.nlm.nih.gov/pubmed/18415807 http://dx.doi.org/10.1080/15412550801940721 |
work_keys_str_mv | AT martinezfernandoj developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps AT raczekanastasiae developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps AT seiferfredericd developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps AT conoscenticraigs developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps AT curticetammyg developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps AT delettothomas developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps AT coteclaudia developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps AT hawkinsclare developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps AT phillipsamyl developmentandinitialvalidationofaselfscoredcopdpopulationscreenerquestionnairecopdps |